ENDRA Life Sciences Inc. (NDRA): R&D Expense
$1.85M
Year ended 2025-12-31
$1.95M
Trailing 12 months to 2026-06-30
-34.4%
3-year compound annual growth
-20.7%
5-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.85M | -42.0% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $3.19M | -36.2% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $5.00M | -23.7% | 2025-04-07, From 2023-01-01 |
| 2022-12-31 | $6.55M | +19.5% | 2024-03-28, From 2022-01-01 |
| 2021-12-31 | $5.48M | -7.4% | 2023-03-16, From 2021-01-01 |
| 2020-12-31 | $5.92M | -10.0% | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $6.57M | +39.2% | 2021-03-25, From 2019-01-01 |
| 2018-12-31 | $4.72M | +144.6% | 2020-03-26, From 2018-01-01 |
| 2017-12-31 | $1.93M | +289.8% | 2019-03-11, From 2017-01-01 |
| 2016-12-31 | $495.4K | n/a | 2018-03-20, From 2016-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| ENDRA Life Sciences Inc. (NDRA) | 2025-12-31 | $1.85M | -42.0% |
| Nexalin Technology, Inc. (NXL) | 2025-12-31 | $1.08M | -9.0% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $753.1K | +9.4% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $2.71M | -15.5% |
| Neuraxis, Inc (NRXS) | 2025-12-31 | $493.6K | +13.8% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $545.0K | +5.4% |
| iTonic Holdings Ltd (ITOC) | 2025-12-31 | $459.1K | +392.0% |
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | $469.0K | -10.8% |
| CapsoVision, Inc (CV) | 2025-12-31 | $18.31M | +21.1% |
Compare NDRA, NXL, ESMC, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗